Mohd Khushman

Medicine & Life Sciences

1. 130-nm albumin-bound paclitaxel 23%
2. Adenocarcinoma 83%
3. Adrenomedullin 17%
4. Anus Neoplasms 18%
5. atezolizumab 20%
6. Bile Duct Neoplasms 18%
7. Biliary Tract Neoplasms 18%
8. Biomarkers 18%
9. Catenins 21%
10. Colorectal Neoplasms 54%
11. Dihydrouracil Dehydrogenase (NADP) 19%
12. DNA Damage 26%
13. Drug Therapy 19%
14. Exosomes 52%
15. Extracellular Vesicles 25%
16. Frailty 54%
17. Gastrointestinal Neoplasms 50%
18. gemcitabine 46%
19. Genes 27%
20. Genotype 20%
21. Geriatric Assessment 70%
22. Growth 22%
23. Hedgehog Proteins 25%
24. Hedgehogs 17%
25. Hepatocellular Carcinoma 21%
26. High-Throughput Nucleotide Sequencing 23%
27. honokiol 20%
28. Immunohistochemistry 21%
29. Immunotherapy 23%
30. Leucine Zippers 17%
31. Meningeal Carcinomatosis 19%
32. Microsatellite Instability 32%
33. Microsatellite Repeats 17%
34. Mortality 17%
35. Mutation 43%
36. Neoplasm Metastasis 52%
37. Neoplasms 100%
38. Neurofibromin 1 20%
39. Pancreatic Neoplasms 99%
40. Pancreatic Stellate Cells 21%
41. Paraneoplastic Syndromes 17%
42. Receptor, Fibroblast Growth Factor, Type 4 22%
43. Receptor-Interacting Protein Serine-Threonine Kinases 18%
44. Registries 43%
45. RNA Sequence Analysis 20%
46. Strongyloides stercoralis 18%
47. Survival 43%
48. Therapeutics 18%
49. Tumor Burden 30%
50. Vitamin B 12 Deficiency 17%